Key facts
- This page summarizes PERCEPTIVE ADVISORS LLC's Form 3 filing for Kardigan, Inc. (KARD).
- 0 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 18 Jun 2026, 11:09.
PERCEPTIVE ADVISORS LLC - 17 Jun 2026 Form 3 Insider Report for Kardigan, Inc. (KARD)
- Reporting relationship
- Director
- Issuer ticker
- KARD
- Reported as of
- 17 Jun 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 18 Jun 2026, 11:09:16 UTC
- Prior SEC filing
- 18 Jun 2026
- Next SEC filing
- 09 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joseph Edelman - for Perceptive Advisors LLC, By: Joseph Edelman, its managing member
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
PERCEPTIVE ADVISORS LLC filed Form 3 for Kardigan, Inc. (KARD) on 18 Jun 2026.
Change
- Previous filing in this sequence was filed on 18 Jun 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (3)
CIK 0001224962
Primary reporting owner
PERCEPTIVE ADVISORS LLC
- Relationship
- Director
- Address
- 51 ASTOR PLACE, 10TH FLOOR, NEW YORK
- Signature
- /s/ Joseph Edelman - for Perceptive Advisors LLC, By: Joseph Edelman, its managing member
- Signature date
- 18 Jun 2026
CIK 0001249675
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
- Relationship
- Director
- Address
- 51 ASTOR PLACE, 10TH FLOOR, NEW YORK
- Signature
- /s/ Joseph Edelman - for Perceptive Life Sciences Master Fund Ltd., By: Perceptive Advisors LLC, its investment manager, By: Joseph Edelman, its managing member
- Signature date
- 18 Jun 2026
CIK 0001164426
EDELMAN JOSEPH
- Relationship
- Director
- Address
- 51 ASTOR PLACE, 10TH FLOOR, NEW YORK
- Signature
- /s/ Joseph Edelman - for Perceptive Capital Solutions Holdings LP, By: Perceptive Capital Solutions GP LLC, its general partner, By: Joseph Edelman, its managing member
- Signature date
- 18 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KARD
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,460,195
- Date
- 17 Jun 2026
- Ownership
- See Footnote
- Footnotes
- F1
KARD
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,460,195
- Date
- 17 Jun 2026
- Ownership
- See Footnote
- Footnotes
- F1
KARD
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,460,195
- Date
- 17 Jun 2026
- Ownership
- See Footnote
- Footnotes
- F1
KARD
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,740,466
- Date
- 17 Jun 2026
- Ownership
- See Footnote
- Footnotes
- F2, F3
KARD
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,740,466
- Date
- 17 Jun 2026
- Ownership
- See Footnote
- Footnotes
- F2, F3
KARD
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,740,466
- Date
- 17 Jun 2026
- Ownership
- See Footnote
- Footnotes
- F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
KARD
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 17 Jun 2026
- Ownership
- See Footnote
- Underlying class
- Common Stock
- Underlying amount
- 80,224
- Exercise price
- $8.00
- Footnotes
- F3, F4, F5
KARD
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 17 Jun 2026
- Ownership
- See Footnote
- Underlying class
- Common Stock
- Underlying amount
- 80,224
- Exercise price
- $8.00
- Footnotes
- F3, F4, F5
KARD
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 17 Jun 2026
- Ownership
- See Footnote
- Underlying class
- Common Stock
- Underlying amount
- 80,224
- Exercise price
- $8.00
- Footnotes
- F3, F4, F5
KARD
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 17 Jun 2026
- Ownership
- See Footnote
- Underlying class
- Common Stock
- Underlying amount
- 33,289
- Exercise price
- $14.71
- Footnotes
- F3, F5, F6
KARD
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 17 Jun 2026
- Ownership
- See Footnote
- Underlying class
- Common Stock
- Underlying amount
- 33,289
- Exercise price
- $14.71
- Footnotes
- F3, F5, F6
KARD
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 17 Jun 2026
- Ownership
- See Footnote
- Underlying class
- Common Stock
- Underlying amount
- 33,289
- Exercise price
- $14.71
- Footnotes
- F3, F5, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager to the Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
Footnote F2
The securities are directly held by Perceptive Capital Solutions Holdings LP ("PCS Holdings"). Perceptive Capital Solutions Advisors LP ("PCS Advisors"), a relying adviser of the Advisor, serves as the investment manager to PCS Holdings, and Perceptive Capital Solutions GP LLC ("PCS GP") serves as the general partner of PCS Holdings.
Footnote F3
Mr. Edelman is the managing member of PCS GP and the Advisor. Each of the Advisor, PCS Advisors, PCS GP, and Mr. Edelman disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
Footnote F4
The shares subject to this option shall vest and become exercisable in three (3) equal annual installments commencing on June 6, 2024, subject to Douglas E. Giordano's continued service as a member of the Issuer's Board of Directors on each such vesting date.
Footnote F5
Consists of options to purchase shares of the Issuer's common stock awarded to Douglas E. Giordano in connection with his service as a member of the Issuer's Board of Directors. Mr. Giordano is a Managing Director and Co-Head of Capital Solutions at the Advisor. The Advisor may be deemed to have an indirect pecuniary interest in the options reported herein because the Advisor has the right to receive the director compensation attributable to Mr. Giordano's board service through a partial management fee offset. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
Footnote F6
The shares subject to this option shall vest and become exercisable on February 9, 2027, subject to Mr. Giordano's continued service as a member of the Issuer's Board of Directors through such vesting date.